Have a feature idea you'd love to see implemented?
Let us know!
NDRA ENDRA Life Sciences Inc
Price (delayed)
$5.27
Market cap
$2.83M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$692.04
Enterprise value
-$767,964
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the
Highlights
The company's EPS has surged by 86% YoY and by 50% QoQ
ENDRA Life Sciences's net income has increased by 26% YoY and by 8% from the previous quarter
NDRA's equity is up by 27% year-on-year but it is down by 27% since the previous quarter
The debt has soared by 164% YoY
Key stats
What are the main financial stats of NDRA
Market
Valuations
Earnings
Shares outstanding
536,908
Market cap
$2.83M
Enterprise value
-$767,964
Price to earnings (P/E)
N/A
Price to book (P/B)
0.03
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$8.82M
EBITDA
-$8.6M
Free cash flow
-$8.07M
Per share
Balance sheet
Liquidity
EPS
-$692.04
Free cash flow per share
-$32.7
Book value per share
$159.56
Revenue per share
$0
TBVPS
$33.95
Total assets
$8.38M
Total liabilities
$1.77M
Debt
$1.15M
Equity
$6.6M
Working capital
$4.15M
Debt to equity
0.17
Current ratio
6.1
Quick ratio
5.83
Net debt/EBITDA
0.42
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-115.1%
Return on equity
-141.3%
Return on invested capital
-263.5%
Return on capital employed
-116.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NDRA stock price
How has the ENDRA Life Sciences stock price performed over time
Intraday
3.94%
1 week
-0.38%
1 month
-31.91%
1 year
-99.69%
YTD
-99.86%
QTD
-25.14%
Financial performance
How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$7.59M
Net income
-$8.82M
Gross margin
N/A
Net margin
N/A
The operating income rose by 39% year-on-year and by 17% since the previous quarter
ENDRA Life Sciences's net income has increased by 26% YoY and by 8% from the previous quarter
Growth
What is ENDRA Life Sciences's growth rate over time
Valuation
What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
0.03
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 86% YoY and by 50% QoQ
NDRA's P/B is 99% less than its 5-year quarterly average of 3.2 and 98% less than its last 4 quarters average of 1.3
NDRA's equity is up by 27% year-on-year but it is down by 27% since the previous quarter
Efficiency
How efficient is ENDRA Life Sciences business performance
The company's return on invested capital rose by 36% YoY and by 18% QoQ
The return on equity has grown by 29% year-on-year and by 13% since the previous quarter
The ROA has increased by 21% year-on-year and by 10% since the previous quarter
Dividends
What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NDRA.
Financial health
How did ENDRA Life Sciences financials performed over time
ENDRA Life Sciences's current ratio has surged by 107% YoY and by 23% QoQ
The total liabilities has declined by 26% year-on-year but it has increased by 22% since the previous quarter
The debt is 83% less than the equity
The debt has soared by 164% YoY
The debt to equity has soared by 113% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.